Indoleamine 2,3-dioxygenase and immune changes under antidepressive treatment in major depression in females

scientific article published in July 2014

Indoleamine 2,3-dioxygenase and immune changes under antidepressive treatment in major depression in females is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID24982234

P2093author name stringVasilios G Masdrakis
Paraskevi Pliatsika
Constantin R Soldatos
Panagiotis Oulis
Stylianos Chatzipanagiotou
Chryssoula Nikolaou
Fotini Boufidou
Margarita Zoga
Charalampos Papageorgiou
Stefania Foteli
P433issue4
P304page(s)633-638
P577publication date2014-07-01
P1433published inIn VivoQ15749806
P1476titleIndoleamine 2,3-dioxygenase and immune changes under antidepressive treatment in major depression in females
P478volume28

Reverse relations

cites work (P2860)
Q37310533Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.
Q89955784Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls
Q37114639Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
Q55022569Overexpression of indoleamine 2, 3-dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway.
Q38888109Plasma Biomarkers of Poor Muscle Quality in Older Men and Women from the Baltimore Longitudinal Study of Aging
Q48130319Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors.
Q57134994Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis
Q47653126p38 predicts depression and poor outcome in esophageal cancer

Search more.